Conditions: Conjunctivitis, Allergic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 127
Healthy volunteers: no

Brief summary:
This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis.

Detailed description:

Arms:
arm 1: One drop of alcaftadine 0.25% ophthalmic solution instilled in each eye at Day 0 and Day 14. arm 2: One drop of olopatadine 0.2% ophthalmic solution instilled in each eye at Day 0 and Day 14. arm 3: One drop of placebo instilled in each eye at Day 0 and Day 14.

Interventions: intervention 1: alcaftadine 0.25% ophthalmic solution intervention 2: olopatadine 0.2% ophthalmic solution intervention 3: dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%
Intervention descriptions: intervention 1: One drop of alcaftadine 0.25% ophthalmic solution instilled in each eye at Day 0 and Day 14. intervention 2: One drop of olopatadine 0.2% ophthalmic solution instilled in each eye at Day 0 and Day 14. intervention 3: One drop of placebo instilled in each eye at Day 0 and Day 14.

Protocol document: